Stericycle, Inc. (NASDAQ:SRCL) Shares Purchased by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC increased its stake in shares of Stericycle, Inc. (NASDAQ:SRCLFree Report) by 23.9% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 557,562 shares of the business services provider’s stock after acquiring an additional 107,562 shares during the period. Allspring Global Investments Holdings LLC owned approximately 0.60% of Stericycle worth $29,411,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of SRCL. Principal Securities Inc. acquired a new position in shares of Stericycle in the 4th quarter valued at approximately $41,000. GAMMA Investing LLC lifted its holdings in shares of Stericycle by 170.9% in the first quarter. GAMMA Investing LLC now owns 818 shares of the business services provider’s stock valued at $43,000 after buying an additional 516 shares during the period. TFO Wealth Partners LLC lifted its holdings in shares of Stericycle by 22,325.0% during the fourth quarter. TFO Wealth Partners LLC now owns 897 shares of the business services provider’s stock valued at $44,000 after purchasing an additional 893 shares during the last quarter. Ramirez Asset Management Inc. purchased a new stake in shares of Stericycle during the third quarter valued at $45,000. Finally, Sachetta LLC purchased a new stake in shares of Stericycle during the fourth quarter valued at $100,000. 98.82% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages have weighed in on SRCL. StockNews.com initiated coverage on Stericycle in a research report on Saturday, June 29th. They issued a “hold” rating on the stock. Truist Financial raised their target price on Stericycle from $50.00 to $62.00 and gave the stock a “hold” rating in a research report on Tuesday, June 4th. Keefe, Bruyette & Woods raised their target price on Stericycle from $135.00 to $142.00 and gave the stock an “outperform” rating in a research report on Tuesday, June 4th. Robert W. Baird cut their target price on Stericycle from $62.00 to $55.00 and set a “neutral” rating for the company in a research report on Friday, April 26th. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and set a $62.00 price target (down from $69.00) on shares of Stericycle in a report on Tuesday, June 4th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $74.00.

Read Our Latest Research Report on SRCL

Stericycle Price Performance

NASDAQ:SRCL opened at $58.37 on Friday. The stock’s 50-day simple moving average is $52.72 and its 200 day simple moving average is $51.08. The company has a market cap of $5.42 billion, a P/E ratio of -265.32, a P/E/G ratio of 3.15 and a beta of 1.11. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.11 and a current ratio of 1.11. Stericycle, Inc. has a 52-week low of $37.78 and a 52-week high of $59.45.

Stericycle (NASDAQ:SRCLGet Free Report) last issued its quarterly earnings results on Thursday, April 25th. The business services provider reported $0.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.03. The business had revenue of $664.90 million during the quarter, compared to analysts’ expectations of $676.42 million. Stericycle had a positive return on equity of 7.31% and a negative net margin of 0.74%. The firm’s revenue for the quarter was down 2.8% compared to the same quarter last year. During the same period in the previous year, the company posted $0.49 earnings per share. As a group, sell-side analysts forecast that Stericycle, Inc. will post 2.32 EPS for the current fiscal year.

Stericycle Profile

(Free Report)

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.

See Also

Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle, Inc. (NASDAQ:SRCLFree Report).

Institutional Ownership by Quarter for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.